154 related articles for article (PubMed ID: 21037547)
1. Metabolic syndrome and liver transplantation.
Hanouneh IA; Zein NN
Minerva Gastroenterol Dietol; 2010 Sep; 56(3):297-304. PubMed ID: 21037547
[TBL] [Abstract][Full Text] [Related]
2. Posttransplant metabolic syndrome: an epidemic waiting to happen.
Pagadala M; Dasarathy S; Eghtesad B; McCullough AJ
Liver Transpl; 2009 Dec; 15(12):1662-70. PubMed ID: 19938136
[TBL] [Abstract][Full Text] [Related]
3. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
[TBL] [Abstract][Full Text] [Related]
4. Obesity, hyperlipidemia, and metabolic syndrome.
Charlton M
Liver Transpl; 2009 Nov; 15 Suppl 2():S83-9. PubMed ID: 19877024
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk factors following orthotopic liver transplantation: predisposing factors, incidence and management.
Desai S; Hong JC; Saab S
Liver Int; 2010 Aug; 30(7):948-57. PubMed ID: 20500807
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome and liver transplantation.
Kadayifci A
Panminerva Med; 2009 Dec; 51(4):205-13. PubMed ID: 20195231
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation in nonalcoholic steatohepatitis is associated with high mortality and post-transplant complications: a single-center experience.
Heuer M; Kaiser GM; Kahraman A; Banysch M; Saner FH; Mathé Z; Gerken G; Paul A; Canbay A; Treckmann JW
Digestion; 2012; 86(2):107-13. PubMed ID: 22846254
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome and liver transplantation: a review and guide to management.
Watt KD; Charlton MR
J Hepatol; 2010 Jul; 53(1):199-206. PubMed ID: 20451282
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease and the metabolic syndrome.
Marchesini G; Babini M
Minerva Cardioangiol; 2006 Apr; 54(2):229-39. PubMed ID: 16778754
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events.
Laryea M; Watt KD; Molinari M; Walsh MJ; McAlister VC; Marotta PJ; Nashan B; Peltekian KM
Liver Transpl; 2007 Aug; 13(8):1109-14. PubMed ID: 17663411
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response.
Younossi ZM; McCullough AJ
Liver Int; 2009 Mar; 29 Suppl 2():3-12. PubMed ID: 19187068
[TBL] [Abstract][Full Text] [Related]
12. Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.
Tilg H; Moschen A
Minerva Gastroenterol Dietol; 2010 Jun; 56(2):159-67. PubMed ID: 20485253
[TBL] [Abstract][Full Text] [Related]
13. The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation.
Mindikoglu AL; Regev A; Casanova-Romero PY; Bejarano PA; Martinez EJ; Tzakis AG; Schiff ER
Transplant Proc; 2006 Jun; 38(5):1440-4. PubMed ID: 16797327
[TBL] [Abstract][Full Text] [Related]
14. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
[TBL] [Abstract][Full Text] [Related]
15. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States.
Nair S; Verma S; Thuluvath PJ
Hepatology; 2002 Jan; 35(1):105-9. PubMed ID: 11786965
[TBL] [Abstract][Full Text] [Related]
16. Nutritional and metabolic issues in solid organ transplantation: targets for future research.
Ward HJ
J Ren Nutr; 2009 Jan; 19(1):111-22. PubMed ID: 19121784
[TBL] [Abstract][Full Text] [Related]
17. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins.
Farges O; Saliba F; Farhamant H; Samuel D; Bismuth A; Reynes M; Bismuth H
Hepatology; 1996 Feb; 23(2):240-8. PubMed ID: 8591847
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease: the mist gradually clears.
de Alwis NM; Day CP
J Hepatol; 2008; 48 Suppl 1():S104-12. PubMed ID: 18304679
[TBL] [Abstract][Full Text] [Related]
19. Liver transplantation and hepatitis C virus. Results in a Spanish center since 1989.
Loinaz C; Lumbreras C; Moreno E; Colina F; Fuertes A; Gómez R; Jiménez C; González-Pinto I; García I; Rojas J; Bellorín C
Hepatogastroenterology; 2001; 48(41):1435-42. PubMed ID: 11677981
[TBL] [Abstract][Full Text] [Related]
20. NAFLD recurrence in liver transplant recipients.
Dureja P; Mellinger J; Agni R; Chang F; Avey G; Lucey M; Said A
Transplantation; 2011 Mar; 91(6):684-9. PubMed ID: 21248661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
